251 related articles for article (PubMed ID: 24998916)
21. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
22. High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a.
Samir R; Asplund A; Tot T; Pekar G; Hellberg D
J Low Genit Tract Dis; 2011 Oct; 15(4):280-6. PubMed ID: 21558960
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women.
Lin ZH; Shen XH; Jin Z; Kim Y; Lee E; Kim H; Kim I
Pathol Int; 2005 Aug; 55(8):491-6. PubMed ID: 15998377
[TBL] [Abstract][Full Text] [Related]
24. Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer.
Kanthiya K; Khunnarong J; Tangjitgamol S; Puripat N; Tanvanich S
Asian Pac J Cancer Prev; 2016; 17(7):3201-6. PubMed ID: 27509952
[TBL] [Abstract][Full Text] [Related]
25. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.
Koo YJ; Hahn HS; Lee IH; Lim KT; Lee KH; Kim HS; Kim TJ; Chun YK; Kim HS; Hong SR
Virchows Arch; 2013 Nov; 463(5):689-96. PubMed ID: 24081504
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of p16, human papillomavirus capsid protein L1 and Ki-67 in cervical intraepithelial lesions: potential utility in diagnosis and prognosis.
Alshenawy HA
Pathol Res Pract; 2014 Dec; 210(12):916-21. PubMed ID: 25149503
[TBL] [Abstract][Full Text] [Related]
27. Expression of Yin Yang 1 in cervical cancer and its correlation with E-cadherin expression and HPV16 E6.
Wang W; Yue Z; Tian Z; Xie Y; Zhang J; She Y; Yang B; Ye Y; Yang Y
PLoS One; 2018; 13(2):e0193340. PubMed ID: 29470526
[TBL] [Abstract][Full Text] [Related]
28. Detection of HPV-induced cervical (pre) neoplastic lesions: a tissue microarray (TMA) study.
Arafa M; Boniver J; Delvenne P
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):422-32. PubMed ID: 18542030
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.
Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Anticancer Res; 2006; 26(2B):1543-56. PubMed ID: 16619570
[TBL] [Abstract][Full Text] [Related]
30. LRIG and cancer prognosis.
Lindquist D; Kvarnbrink S; Henriksson R; Hedman H
Acta Oncol; 2014 Sep; 53(9):1135-42. PubMed ID: 25180912
[TBL] [Abstract][Full Text] [Related]
31. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
[TBL] [Abstract][Full Text] [Related]
32. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer.
Amortegui AJ; Meyer MP; Elborne VL; Amin RM
Mod Pathol; 1995 Dec; 8(9):907-12. PubMed ID: 8751330
[TBL] [Abstract][Full Text] [Related]
33. Survivin and telomerase expression in the uterine cervix of women with human papillomavirus-induced lesions.
Barbosa LC; da Silva ID; Corrêa JC; Ribalta JC
Int J Gynecol Cancer; 2011 Jan; 21(1):15-21. PubMed ID: 21330827
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia.
Sano T; Masuda N; Oyama T; Nakajima T
Pathol Int; 2002; 52(5-6):375-83. PubMed ID: 12100520
[TBL] [Abstract][Full Text] [Related]
35. High risk HPV and p53 protein expression in cervical intraepithelial neoplasia.
Vassallo J; Derchain SF; Pinto GA; Martinez EZ; Syrjänen KJ; Andrade LA
Int J Gynaecol Obstet; 2000 Oct; 71(1):45-8. PubMed ID: 11044541
[TBL] [Abstract][Full Text] [Related]
36. In vivo cyclin E expression as a marker for early cervical neoplasia.
Quade BJ; Park JJ; Crum CP; Sun D; Dutta A
Mod Pathol; 1998 Dec; 11(12):1238-46. PubMed ID: 9872657
[TBL] [Abstract][Full Text] [Related]
37. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of nuclear factor-kappaB (NF-kappaB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer.
Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen S; Favalli C; Syrjänen K;
Diagn Cytopathol; 2006 Aug; 34(8):555-63. PubMed ID: 16850495
[TBL] [Abstract][Full Text] [Related]
39. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
[TBL] [Abstract][Full Text] [Related]
40. Distribution of HPV infection and tumour markers in cervical intraepithelial neoplasia from cone biopsies of Mozambican women.
Carrilho C; Cirnes L; Alberto M; Buane L; Mendes N; David L
J Clin Pathol; 2005 Jan; 58(1):61-8. PubMed ID: 15623485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]